Benzodiazepines, benzodiazepine-like drugs, and typical antipsychotics impair manual dexterity in patients with schizophrenia

Journal of Psychiatric Research

Volumn 49, Issue 1, 2014, Pages 37-42

  Sasayama, Daimei ^a,b   Hori, Hiroaki ^a   Teraishi, Toshiya ^a   Hattori, Kotaro ^a   Ota, Miho ^a   Matsuo, Junko ^a   Kinoshita, Yukiko ^a   Okazaki, Mitsutoshi ^c   Arima, Kunimasa ^c   Amano, Naoji ^b   Higuchi, Teruhiko ^c   Kunugi, Hiroshi ^a  

^a NATIONAL INSTITUTE OF NEUROSCIENCE   (Japan)

^b SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c NATIONAL INSTITUTE OF MENTAL HEALTH   (Japan)

Author keywords

Antipsychotics; Benzodiazepines; Dexterity; Schizophrenia

Indexed keywords

ARIPIPRAZOLE; ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE DERIVATIVE; BROMAZEPAM; BROTIZOLAM; CHLORPROMAZINE; CLONAZEPAM; ESTAZOLAM; ETIZOLAM; FLUNITRAZEPAM; FLUPHENAZINE; FLURAZEPAM; HALOPERIDOL; HALOXAZOLAM; LEVOMEPROMAZINE; LOFLAZEPATE; LORAZEPAM; NEUROLEPTIC AGENT; NITRAZEPAM; OLANZAPINE; PERICIAZINE; PEROSPIRONE; QUETIAPINE; RILMAZAFONE; RISPERIDONE; SULPIRIDE; SULTOPRIDE; TRIAZOLAM; ZOLPIDEM; ZOTEPINE;

ADULT; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GRIP STRENGTH; HAND GRIP; HUMAN; IMPAIRED DEXTERITY; MAJOR CLINICAL STUDY; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOLOGIC TEST; PURDUE PEGBOARD TEST; SCHIZOPHRENIA; TREATMENT OUTCOME; YOUNG ADULT;

ANTIPSYCHOTICS; BENZODIAZEPINES; DEXTERITY; SCHIZOPHRENIA;

ADULT; ANTIPSYCHOTIC AGENTS; BENZODIAZEPINES; CASE-CONTROL STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; HAND STRENGTH; HUMANS; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR DISORDERS; PSYCHOMOTOR PERFORMANCE; SCHIZOPHRENIA; STATISTICS AS TOPIC;

EID: 84891143247     PISSN: 00223956     EISSN: 18791379     Source Type: Journal    
DOI: 10.1016/j.jpsychires.2013.10.019     Document Type: Article

References (29)

1. American Psychiatric Association DSM-IV: Diagnostic and statistical manual of mental disorders 1994, American Psychiatric Press, Washington D.C. 4th ed.
2. Dold M., Li C., Gillies D., Leucht S. Benzodiazepine augmentation of antipsychotic drugs in schizophrenia: a meta-analysis and Cochrane review of randomized controlled trials. Eur Neuropsychopharmacol 2013, 23:1023-1033.
3. Dold M., Li C., Tardy M., Khorsand V., Gillies D., Leucht S. Benzodiazepines for schizophrenia. Cochrane Database Syst Rev 2012, 11:CD006391.
4. Gorenstein C., Bernik M.A., Pompeia S. Differential acute psychomotor and cognitive effects of diazepam on long-term benzodiazepine users. Int Clin Psychopharmacol 1994, 9:145-153.
5. Gschwandtner U., Pfluger M., Aston J., Borgwardt S., Drewe M., Stieglitz R.D., et al. Fine motor function and neuropsychological deficits in individuals at risk for schizophrenia. Eur Arch Psychiatry Clin Neurosci 2006, 256:201-206.
6. Hori H., Teraishi T., Sasayama D., Hattori K., Ota M., Matsuo J., et al. Schizotypal trait in healthy women is associated with a shift away from dextrality on a spatial motor control task, but not on a force control task. Psychiatry Res 2012, 200:629-634.
7. Huang M.Y., Matsuura N., Kaneko Y., Ichinohe T. Midazolam increases bite force during intravenous sedation. JOral Maxillofac Surg 2012, 70:e458-463.
8. Igarashi Y., Hayashi N., Yamashina M., Otsuka N., Kuroki N., Anzai N., et al. Interrater reliability of the Japanese version of the Positive and Negative Syndrome Scaleand the appraisal of its training effect. Psychiatry Clin Neurosci 1998, 52:467-470.
9. Equivalent dose of psychotropics 1999, Seiwa Shoten, Tokyo. A. Inagaki, T. Inada, Y. Fujii, G. Yagi (Eds.).
10. Jahn T., Hubmann W., Karr M., Mohr F., Schlenker R., Heidenreich T., et al. Motoric neurological soft signs and psychopathological symptoms in schizophrenic psychoses. Psychiatry Res 2006, 142:191-199.
11. Kay S.R., Fiszbein A., Opler L.A. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13:261-276.
12. Langenecker S.A., Saunders E.F., Kade A.M., Ransom M.T., McInnis M.G. Intermediate: cognitive phenotypes in bipolar disorder. JAffect Disord 2010, 122:285-293.
13. Leucht S., Pitschel-Walz G., Abraham D., Kissling W. Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo. A meta-analysis of randomized controlled trials. Schizophr Res 1999, 35:51-68.
14. Loring D.W., Marino S.E., Parfitt D., Finney G.R., Meador K.J. Acute lorazepam effects on neurocognitive performance. Epilepsy Behav 2012, 25:329-333.
15. McKean A., Vella-Brincat J. Ten-year dispensing trends of hypnotics in New Zealand. NZ Med J 2011, 124:108-110.
16. McManus I.C., Ankier S.I., Norfolk J., Phillips M., Priest R.G. Effects on psychological performance of the benzodiazepine, loprazolam, alone and with alcohol. Br J Clin Pharmacol 1983, 16:291-300.
17. Meltzer H.Y. Update on typical and atypical antipsychotic drugs. Annu Rev Med 2013, 64:393-406.
18. Midorikawa A., Hashimoto R., Noguchi H., Saitoh O., Kunugi H., Nakamura K. Impairment of motor dexterity in schizophrenia assessed by a novel finger movement test. Psychiatry Res 2008, 159:281-289.
19. Morgan K., Adam K., Oswald I. Effect of loprazolam and of triazolam on psychological functions. Psychopharmacol (Berl) 1984, 82:386-388.
20. Otsubo T., Tanaka K., Koda R., Shinoda J., Sano N., Tanaka S., et al. Reliability and validity of Japanese version of the Mini-International Neuropsychiatric Interview. Psychiatry Clin Neurosci 2005, 59:517-526.
21. Sasayama D., Hori H., Teraishi T., Hattori K., Ota M., Matsuo J., et al. More severe impairment of manual dexterity in bipolar disorder compared to unipolar major depression. JAffect Disord 2012, 136:1047-1052.
22. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. JClin Psychiatry 1998, 59(Suppl.20):22-33. quiz 34-57.
23. Sponheim S.R., Jung R.E., Seidman L.J., Mesholam-Gately R.I., Manoach D.S., O'Leary D.S., et al. Cognitive deficits in recent-onset and chronic schizophrenia. JPsychiatr Res 2010, 44:421-428.
24. Szoke A., Meary A., Trandafir A., Bellivier F., Roy I., Schurhoff F., et al. Executive deficits in psychotic and bipolar disorders - implications for our understanding of schizoaffective disorder. Eur Psychiatry 2008, 23:20-25.
25. Tiffin J., Asher E.J. The Purdue pegboard; norms and studies of reliability and validity. JAppl Psychol 1948, 32:234-247.
26. Tomita S., Matsuura N., Ichinohe T. The combined effects of midazolam and propofol sedation on muscle power. Anaesthesia 2013, 68:478-483.
27. Wobrock T., Falkai P., Schneider-Axmann T., Hasan A., Galderisi S., Davidson M., et al. Comorbid substance abuse in first-episode schizophrenia: effects on cognition and psychopathology in the EUFEST study. Schizophr Res 2013, 147:132-139.
28. Yamada H., Masui K., Kikuimoto K. The Japanese version of the positive and negative syndrome scale (PANSS) rating manual 1991, Seiwa, Tokyo.
29. Zammit G. Comparative tolerability of newer agents for insomnia. Drug Saf 2009, 32:735-748.